ZA969490B - Compounds useful for the inhibition of the replication of hiv-1 and hiv-1 mutants - Google Patents
Compounds useful for the inhibition of the replication of hiv-1 and hiv-1 mutantsInfo
- Publication number
- ZA969490B ZA969490B ZA969490A ZA969490A ZA969490B ZA 969490 B ZA969490 B ZA 969490B ZA 969490 A ZA969490 A ZA 969490A ZA 969490 A ZA969490 A ZA 969490A ZA 969490 B ZA969490 B ZA 969490B
- Authority
- ZA
- South Africa
- Prior art keywords
- hiv
- mutants
- replication
- inhibition
- compounds useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/565,493 US5696151A (en) | 1995-11-30 | 1995-11-30 | Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA969490B true ZA969490B (en) | 1997-06-02 |
Family
ID=24258853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA969490A ZA969490B (en) | 1995-11-30 | 1996-11-12 | Compounds useful for the inhibition of the replication of hiv-1 and hiv-1 mutants |
Country Status (21)
Country | Link |
---|---|
US (1) | US5696151A (pt) |
EP (1) | EP0874839B1 (pt) |
JP (1) | JP3027771B2 (pt) |
KR (1) | KR100505841B1 (pt) |
CN (1) | CN1098847C (pt) |
AP (1) | AP902A (pt) |
AT (1) | ATE224382T1 (pt) |
AU (1) | AU704086B2 (pt) |
BR (1) | BR9611838A (pt) |
CA (1) | CA2237194C (pt) |
DE (1) | DE69623819T2 (pt) |
DK (1) | DK0874839T3 (pt) |
ES (1) | ES2183986T3 (pt) |
HK (1) | HK1016601A1 (pt) |
HU (1) | HU223660B1 (pt) |
NZ (1) | NZ324118A (pt) |
OA (1) | OA10864A (pt) |
PT (1) | PT874839E (pt) |
TW (1) | TW448169B (pt) |
WO (1) | WO1997019940A1 (pt) |
ZA (1) | ZA969490B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6143780A (en) * | 1999-09-17 | 2000-11-07 | Uniroyal Chemical Company, Inc. | N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV |
US6017947A (en) * | 1999-09-17 | 2000-01-25 | Brouwer; Walter Gerhard | Heterocyclic carbodithioperoxyimidic compounds useful for the inhibition of the replication of HIV |
US7064139B2 (en) * | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
US6498254B1 (en) * | 2001-10-29 | 2002-12-24 | Uniroyal Chemical Company, Inc. | Antiretroviral compounds and compositions |
DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
DE102008015032A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
CN101987842A (zh) * | 2009-07-31 | 2011-03-23 | 上海开拓者医药发展有限公司 | 一种2-甲基噻吩衍生物的制备方法 |
JP2017522334A (ja) * | 2014-07-24 | 2017-08-10 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 殺真菌性ピラゾール誘導体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268389A (en) * | 1989-10-16 | 1993-12-07 | Uniroyal Chemical Company, Inc. | Thiocarboxylate ester compounds compositions containing the same |
US5968910A (en) * | 1994-11-30 | 1999-10-19 | Jan M. R. Balzarini | Compositions containing two or three inhibitors of different HIV reverse transcriptases |
-
1995
- 1995-11-30 US US08/565,493 patent/US5696151A/en not_active Expired - Lifetime
-
1996
- 1996-11-08 TW TW085113662A patent/TW448169B/zh not_active IP Right Cessation
- 1996-11-12 ZA ZA969490A patent/ZA969490B/xx unknown
- 1996-11-15 PT PT96942010T patent/PT874839E/pt unknown
- 1996-11-15 DE DE69623819T patent/DE69623819T2/de not_active Expired - Lifetime
- 1996-11-15 WO PCT/US1996/018394 patent/WO1997019940A1/en active IP Right Grant
- 1996-11-15 KR KR10-1998-0703958A patent/KR100505841B1/ko active IP Right Grant
- 1996-11-15 CA CA002237194A patent/CA2237194C/en not_active Expired - Lifetime
- 1996-11-15 AT AT96942010T patent/ATE224382T1/de active
- 1996-11-15 HU HU9901990A patent/HU223660B1/hu active IP Right Grant
- 1996-11-15 AP APAP/P/1998/001245A patent/AP902A/en active
- 1996-11-15 DK DK96942010T patent/DK0874839T3/da active
- 1996-11-15 EP EP96942010A patent/EP0874839B1/en not_active Expired - Lifetime
- 1996-11-15 BR BR9611838A patent/BR9611838A/pt active Search and Examination
- 1996-11-15 ES ES96942010T patent/ES2183986T3/es not_active Expired - Lifetime
- 1996-11-15 AU AU11199/97A patent/AU704086B2/en not_active Expired
- 1996-11-15 JP JP9520533A patent/JP3027771B2/ja not_active Expired - Lifetime
- 1996-11-15 CN CN96198705A patent/CN1098847C/zh not_active Expired - Lifetime
- 1996-11-15 NZ NZ324118A patent/NZ324118A/xx not_active IP Right Cessation
-
1998
- 1998-05-29 OA OA9800070A patent/OA10864A/en unknown
-
1999
- 1999-04-21 HK HK99101720A patent/HK1016601A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2183986T3 (es) | 2003-04-01 |
AU1119997A (en) | 1997-06-19 |
HK1016601A1 (en) | 1999-11-05 |
DE69623819D1 (de) | 2002-10-24 |
PT874839E (pt) | 2003-02-28 |
HUP9901990A3 (en) | 2000-08-28 |
EP0874839A1 (en) | 1998-11-04 |
AU704086B2 (en) | 1999-04-15 |
AP902A (en) | 2000-11-23 |
NZ324118A (en) | 1999-02-25 |
EP0874839B1 (en) | 2002-09-18 |
DK0874839T3 (da) | 2003-01-27 |
KR19990071682A (ko) | 1999-09-27 |
KR100505841B1 (ko) | 2005-12-14 |
JPH11504657A (ja) | 1999-04-27 |
US5696151A (en) | 1997-12-09 |
CN1098847C (zh) | 2003-01-15 |
HUP9901990A2 (en) | 2000-07-28 |
CA2237194C (en) | 2006-06-13 |
AP9801245A0 (en) | 1998-06-30 |
OA10864A (en) | 2003-02-18 |
HU223660B1 (hu) | 2004-11-29 |
JP3027771B2 (ja) | 2000-04-04 |
WO1997019940A1 (en) | 1997-06-05 |
CA2237194A1 (en) | 1997-06-05 |
BR9611838A (pt) | 1999-03-09 |
TW448169B (en) | 2001-08-01 |
CN1203596A (zh) | 1998-12-30 |
DE69623819T2 (de) | 2003-05-28 |
ATE224382T1 (de) | 2002-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6594796A (en) | Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases | |
PL323904A1 (en) | C-4' modified inhibitors of andenosinic kinase | |
PL322277A1 (en) | Derivatives of pyrazol-4-ylobenzoyl | |
ZA962879B (en) | A pharmaceutical composition for inhibiting the growth of viruses and cancers | |
PL324451A1 (en) | Derivatives of diphenylmethylenepiperidine | |
ZA962881B (en) | A pharmaceutical composition for inhibiting the growth of viruses and cancers | |
AU6774294A (en) | Methods of preventing viral replication | |
AU1448092A (en) | Splitter and method of forming it | |
ZA962878B (en) | A pharmaceutical composition for inhibiting the growth of viruses and cancers | |
AU673375B2 (en) | Process for the duplication or construction of a copy of a denture and the product thereby obtained | |
AU4965797A (en) | Process for producing nucleoside 5'-triphosphates and application of the same | |
ZA969490B (en) | Compounds useful for the inhibition of the replication of hiv-1 and hiv-1 mutants | |
EP0722949A3 (en) | Process for the preparation of cyclopentadienyl compounds and compounds produced by the process | |
ZA962880B (en) | A pharmaceutical composition for inhibiting the growth of viruses and cancers | |
AU4248297A (en) | Inhibition of viral replication | |
GB9621852D0 (en) | Inhibition of scale | |
HUP9903481A3 (en) | Process for the preparation of 1-aryl-1-cyanocyclobutane derivatives | |
AU6962894A (en) | Compositions and methods for inhibiting replication of human immunodeficiency virus-1 | |
EP0833668A4 (en) | INHIBITATION OF THE HEPATITIS B VIRUS REPLICATION | |
AU6378598A (en) | Method for inhibition of virus replication | |
AU6274694A (en) | Methods and compositions for the inhibition of complement activation | |
EP0761720A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
IL114300A0 (en) | Improved methods for the determination and adjustment of prolacting daily rhythms | |
AU6658796A (en) | Process for the modification of toxic and/or off-flavoured compounds | |
EP0823256A4 (en) | PREVENTIVE OR THERAPEUTIC MEDICINE, OR BOTH, FOR ISCHEMIC CONDITIONS |